STEMCELL Journal Club: Patient-Derived Alzheimer’s Disease Modeling
Dr. Erin Knock discusses the applications of pluripotent stem cell-derived lines to investigate Alzheimer's Disease
In this Journal Club, Dr. Erin Knock discusses the applications of pluripotent stem cell-derived lines to investigate Alzheimer’s Disease. The featured paper is Ortiz-Virumbrales et al.’s CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2N141I neurons.
Publish Date:
May 25, 2020
Related Multimedia
-
STEMCELL Journal Club: Mechanisms of Glioblastoma Resistance
Publish Date: May 25, 2020 -
STEMCELL Journal Club: Cerebral Organoids for Human-Specific Infection Modeling
Publish Date: May 25, 2020 -
Modeling Genetic Epilepsies with Induced Pluripotent Stem Cells
Publish Date: June 01, 2017
Item added to your cart

STEMCELL Journal Club: Patient-Derived Alzheimer’s Disease Modeling
Explore Our Products
-
Serum-free neurophysiological basal medium for improved neuronal function
-
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells
-
NeuroCult™ SM1 Neuronal Supplement
Supplement (50X) for the serum-free culture of neurons -
STEMdiff™ SMADi Neural Induction Kit
Serum-free medium kit for highly efficient SMAD inhibition-mediated neural induction of human ES and iPS cells